Skip to content
Search

Latest Stories

Pharmacists witness impact of prescription charges on people in England, RPS survey reveals

The result from the Royal Pharmaceutical Society (RPS)’s survey showed that pharmacists witnessed ‘the cost of living is having an impact on whether people can afford prescription medicines in England’.

RPS has long campaigned to remove prescription charges for people with long-term conditions in England because they create a financial barrier to patients receiving the medicines needed to keep them well.


The charge currently stands at £9.35 per item prescrib9ed and an annual rise usually occurs in April. Prescriptions are free for people in Scotland, Wales and Northern Ireland.

One in two pharmacists who responded to the survey said they’ve seen an increase in the last six months in patients asking them which medicines on their prescription they can 'do without' due to affordability issues.

One in two pharmacists had seen a rise in people not collecting their prescription, whilst two out of three pharmacists reported an increase in being asked if there was a cheaper, over-the-counter substitute for the medicine they had been prescribed.

Chair of the RPS in England Ms Thorrun Govind said: “We are deeply concerned that people are having to make choices about their health based on their ability to pay. No one should have to make choices about rationing their medicines and no one should be faced with a financial barrier to getting the medicines they need.

“Prescription charges are an unfair tax on health which disadvantages working people on lower incomes who are already struggling with food and energy bills.

“Reducing access to medicines leads to poorer health, time off work and can result in admissions to hospital, the cost of which must be set against any income gained from prescription charges.

“Prescriptions have been free for people in Scotland, Wales and Northern Ireland for many years. We urgently need an overhaul of the system in England to ensure it supports access to medicines for people with long-term conditions at the sharp end of the cost of living crisis.

“Ultimately we want to see the prescription charge abolished for people with long-term conditions so medicines are free to access in England, just like they are in the rest of the UK.”

Tips from RPS for saving money on medicines include:

  • Depending on how many medicines you need it may be cheaper to buy a prescription ‘season ticket’ known as a prescription prepayment certificate available from the NHS. You will save money if you need more than 3 items in 3 months, or 11 items in 12 months.
  • Ask your pharmacist if there is an equivalent medicine costing less than the charge which you can buy over the counter
  • Ask your pharmacist or GP to review your medicines to ensure they are appropriate and that you get the best out of them.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less